Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Keller-Stanislawski

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 26, 2017
[Counterfeit medicines]Brigitte Keller-Stanislawski, Norbert Paeschke
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 3, 2018
Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016Dirk Mentzer, Doris Oberle, Brigitte Keller-Stanislawski
Deutsches Arzteblatt International|May 28, 2009
Vaccination safety updateBurkhard Schneeweiss, Michael Pfleiderer, Brigitte Keller-Stanislawski
Pharmacoepidemiology and Drug Safety|August 16, 2017
Spontaneous reporting of suspected narcolepsy after vaccination against pandemic influenza A (H1N1) in GermanyDoris Oberle, Jutta Pavel, Brigitte Keller-Stanislawski
Medizinische Klinik (Munich, Germany : 1983)|August 21, 2003
[Suspected cases of severe side effects after infliximab (Remicade) in Germany]Tilo Andus, Eduard F Stange, Dieter Höffler, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 23, 2015
[Safety monitoring of cell-based medicinal products (CBMPs)]Markus B Funk, Marion Frech, Robert Spranger, et al.
Pharmacoepidemiology and Drug Safety|August 2, 2024
Adverse Menstrual Events Reported After and Before (or Without) COVID-19 Vaccination: A Systematic Review and Meta-Analysis of Comparative Observational StudiesFrank Peinemann, Doris Oberle, Ursula Drechsel-Bäuerle, et al.
Vaccines|April 27, 2026
Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic ModelKarin Weisser, Niklas Hartung, Gaby Wangorsch, et al.
Sleep Medicine|May 20, 2017
Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in GermanyDoris Oberle, Jutta Pavel, Geert Mayer, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 26, 2025
Model-informed exploration of the boundaries of safe aluminium exposure from allergen immunotherapy in childrenKarin Weisser, Gaby Wangorsch, Niklas Hartung, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 26, 2017
[Counterfeit medicines]Brigitte Keller-Stanislawski, Norbert Paeschke
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 3, 2018
Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016Dirk Mentzer, Doris Oberle, Brigitte Keller-Stanislawski
Deutsches Arzteblatt International|May 28, 2009
Vaccination safety updateBurkhard Schneeweiss, Michael Pfleiderer, Brigitte Keller-Stanislawski
Pharmacoepidemiology and Drug Safety|August 16, 2017
Spontaneous reporting of suspected narcolepsy after vaccination against pandemic influenza A (H1N1) in GermanyDoris Oberle, Jutta Pavel, Brigitte Keller-Stanislawski
Medizinische Klinik (Munich, Germany : 1983)|August 21, 2003
[Suspected cases of severe side effects after infliximab (Remicade) in Germany]Tilo Andus, Eduard F Stange, Dieter Höffler, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 23, 2015
[Safety monitoring of cell-based medicinal products (CBMPs)]Markus B Funk, Marion Frech, Robert Spranger, et al.
Pharmacoepidemiology and Drug Safety|August 2, 2024
Adverse Menstrual Events Reported After and Before (or Without) COVID-19 Vaccination: A Systematic Review and Meta-Analysis of Comparative Observational StudiesFrank Peinemann, Doris Oberle, Ursula Drechsel-Bäuerle, et al.
Vaccines|April 27, 2026
Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic ModelKarin Weisser, Niklas Hartung, Gaby Wangorsch, et al.
Sleep Medicine|May 20, 2017
Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in GermanyDoris Oberle, Jutta Pavel, Geert Mayer, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 26, 2025
Model-informed exploration of the boundaries of safe aluminium exposure from allergen immunotherapy in childrenKarin Weisser, Gaby Wangorsch, Niklas Hartung, et al.
Pageof 6